Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / COM
-
Number of holders
-
168
-
Total 13F shares, excl. options
-
42,933,190
-
Shares change
-
+4,675,677
-
Total reported value, excl. options
-
$2,329,098,644
-
Value change
-
+$249,794,827
-
Put/Call ratio
-
144%
-
Number of buys
-
84
-
Number of sells
-
73
-
Price
-
$54.25
Institutional Holders of AERIE PHARMACEUTICALS INC - COM (AERI) as of Q1 2018
As of 31 Mar 2018 AERIE PHARMACEUTICALS INC - COM (AERI) had 210 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 42,933,190 shares of stock of the company.
Largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, ADAGE CAPITAL PARTNERS GP, L.L.C., Partner Fund Management, L.P., BlackRock Inc., Foresite Capital Management III, LLC, ORBIMED ADVISORS LLC, Foresite Capital Management II, LLC, JENNISON ASSOCIATES LLC, and Invesco Ltd..
This table shows 210 institutional shareholders of the security as of 31 Mar 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.